M. Mouroux

发表

Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states

O. Hassani, A. Parent, E. Hirsch, 1997, Neuroscience.

Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus

O. Hassani, M. Mouroux, J. Féger, 1996, Neuroscience.

The Subthalamic Nucleus: A More Complex Structure than Expected

A. Benazzouz, T. Boraud, M. Mouroux, 1994 .

Resistance profile and cross‐resistance of HIV‐1 among patients failing a non‐nucleoside reverse transcriptase inhibitor‐containing regimen *

M. Mouroux, V. Calvez, C. Delaugerre, 2001, Journal of medical virology.

MIKADO: a multicentre, open‐label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine

M. Mouroux, V. Calvez, C. Katlama, 2001, HIV medicine.

Electrophysiological study of the excitatory parafascicular projection to the subthalamic nucleus and evidence for ipsi- and contralateral controls

O. Hassani, M. Mouroux, J. Féger, 1995, Neuroscience.

HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment.

M. Mouroux, V. Calvez, C. Rouzioux, 2000, AIDS research and human retroviruses.

Increase of HIV-1 Pro-Viral Dna per Million Peripheral Blood Mononuclear Cells in Patients with Advanced HIV Disease (Cd4<200 Cells/Mm3) Receiving Interleukin 2 Combined with Haart Versus Haart Alone (Anrs-082 Trial)

M. Mouroux, V. Calvez, G. Carcelain, 2002, Antiviral therapy.

Mutations in the human immunodeficiency virus type 1 reverse transcriptase gene observed in stavudine and didanosine strains obtained by in vitro passages.

M. Mouroux, V. Calvez, H. Agut, 1998, Research in virology.

Low-Rate Emergence of Thymidine Analogue Mutations and Multi-Drug Resistance Mutations in the HIV-1 Reverse Transcriptase Gene in Therapy-Naive Patients Receiving Stavudine plus Lamivudine Combination Therapy

M. Mouroux, V. Calvez, F. Brun-Vézinet, 2000, Antiviral therapy.

Electrophysiological and Fos immunohistochemical evidence for the excitatory nature of the parafascicular projection to the globus pallidus

O. Hassani, M. Mouroux, J. Féger, 1997, Neuroscience.

Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor

M. Mouroux, V. Calvez, H. Agut, 1999, Journal of Clinical Microbiology.

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure.

M. Mouroux, V. Calvez, G. Carcelain, 2001, AIDS.

Early Virological Failure in Naive Human Immunodeficiency Virus Patients Receiving Saquinavir (Soft Gel Capsule)-Stavudine-Zalcitabine (MIKADO Trial) Is Not Associated with Mutations Conferring Viral Resistance

M. Mouroux, V. Calvez, C. Delaugerre, 2000, Journal of Clinical Microbiology.

Prevalence and Conditions of Selection of E44D/A and V118I Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in Clinical Practice

M. Mouroux, V. Calvez, C. Delaugerre, 2001, Antimicrobial Agents and Chemotherapy.

The Relationships Between Subthalamic Nucleus, Globus Pallidus and Thalamic Parafascicular Nucleus

O. Hassani, M. Mouroux, J. Féger, 1996 .

Evidence that the parafascicular projection to the subthalamic nucleus is glutamatergic.

M. Mouroux, J. Féger, J Féger, 1993, Neuroreport.

Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6‐OHDA lesion in the rat brain

O. Hassani, M. Mouroux, J. Féger, 2001, Movement disorders : official journal of the Movement Disorder Society.